fda compounding semaglutide crackdown news today 2025 Troubling Findings in Study of GLP-1 Compounders Counterfeit Ozempic Crackdown: Drugmakers Threaten

Less Common, More Concerning: Eye and Vision Problems More recently, researchers have started sounding the alarm about vision complications, including: NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy) sudden, painless vision loss caused by damage to the optic nerve

Zepbound for obstructive sleep apnea FDA-approved in December 2024 for moderate-to-severe obstructive sleep apnea in obese adults

Results Patients with a high cumulative dose of GLP-1 agonist are associated with a higher risk of developing drug-induced pancreatitis associated with GLP-1 agonists, indicated by a statistically significant odds ratio

It was observed that the animals which received Retatrutide treatment in the diabetic state, had better performance on spatial learning, short-term memory, attenuated neuroinflammatory markers and preserved hippocampal-cortical structure compared to the untreated diabetic rats

The Semaglutide / Methylcobalamin / Glycine Injection (5mg/1mg/10mg/mL) is more than a typical weight loss therapy

Blood pressure